ANUSOL-HC is available as either a 2.5% hydrocortisone cream or a 25 mg hydrocortisone acetate suppository to provide soothing relief from anal itching, burning, and inflammation.
There are many potential causes of anal itching, or pruritis ani. One of the most common causes of anal itching and inflammation are inflamed hemorrhoids. At least 50% of Americans will experience hemorrhoids that cause some degree of pain or itching during their lifetime. Additional causes of anal itching and inflammation include fissures (tears) of the skin around the anus, perspiration, stool deposits, diarrhea, and psoriasis.
ANUSOL-HC cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Applied as a thin film to the affected area using a convenient, easily inserted dispensing cap, the concentrated cream forms a protective coating over tissues with no greasy build-up.
The suppository is indicated for use in inflamed hemorrhoids and post-irradiation (factitial) proctitis and as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of the anorectum, and pruritis ani. Providing symptom relief as the product is absorbed, the suppository offers easy, consistent administration for itching and inflammation within the anorectum.
PROCTOCORT is available either as a 1% hydrocortisone cream or a 30 mg hydrocortisone acetate suppository to provide soothing relief from anal itching, burning, and inflammation.
Like ANUSOL-HC, the cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The cream is a nonstaining, water-miscible preparation with a mild unique acid mantle base.
The suppository is also indicated for the same conditions as ANUSOL-HC, including use in inflamed hemorrhoids and post-irradiation (factitial) proctitis and as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of the anorectum, and pruritis ani. The suppository provides convenient, accurate, and consistent dose administration for problems requiring a higher potency agent.
Important Safety Information about ANUSOL-HC and PROCTOCORT
ANUSOL-HCANUSOL-HC® (hydrocortisone cream, 2.5%) and
PROCTOCORTPROCTOCORT® (hydrocortisone cream, 1%) are both indicated for the relief of the inflammatory and
pruritic manifestations of corticosteroid-responsive dermatoses.
ANUSOL-HC® (hydrocortisone acetate suppository, 25 mg) and PROCTOCORT® (hydrocortisone acetate suppository, 30 mg) are both indicated
for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic Ulcerative Colitis, cryptitis, and other inflammatory conditions of the anorectum, and
ANUSOL-HC and PROCTOCORT are contraindicated in patients with a history of hypersensitivity to any of the components. Adverse effects include various types of skin and hair follicle irritation such as burning and
itching, which may necessitate discontinuing product. Any infection should be treated; if response is not prompt, the corticosteroid should be discontinued until the infection clears. These products are in Pregnancy
Category C; therefore, topical corticosteroids should be used during the pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant
patients, in large amounts, or for prolonged periods of time. Caution is advised for use in nursing mothers.
Creams: If hypothalamic-pituitary-adrenal (HPA) axis suppression occurs, withdraw the drug, and use supplemental systemic corticosteroid (if necessary), reduce frequency of application, or substitute
less potent steroid. Treated skin should not be bandaged or otherwise covered unless directed by a physician. If infection develops when using occlusive dressings, discontinue dressings and institute antimicrobial
therapy. For pediatric patients use in smallest area possible and avoid chronic use, as pediatric patients may be more susceptible to systemic toxicity.
Suppositories: Products should not be used unless an adequate proctologic examination has been made.
Consult with your physician to see if this product is right for you.
Please see complete Prescribing Information about ANUSOL-HC and PROCTOCORT:
ANUSOL-HC® Hydrocortisone Cream, 2.5%
PROCTOCORT® Hydrocortisone Cream, 1%
For ANUSOL-HC® Hydrocortisone Acetate Suppository, 25 mg
For PROCTOCORT® Hydrocortisone Acetate Suppository, 30 mg
The information contained on this page is intended for US residents, healthcare providers, and pharmacists only.
For product information, adverse event reports, and product complaint reports please call:
Salix Product Information Call Center